RYLPF (Koninklijke Philips NV) Days Sales Outstanding: 77.63 (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RYLPF Koninklijke Philips NV RYLPF
69 GF Score
Price $26.77
GF Value $25.41
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Days Sales Outstanding?

Koninklijke Philips NV RYLPF -3.83% 69 Days Sales Outstanding is 77.63 as of Mar. 2026, which is 0% below its 10-year median of 77.65. GuruFocus rates RYLPF with a GF Score™ of 69/100 and a GF Value™ of $25.41 (Fairly Valued). The stock has 2 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Koninklijke Philips NV ranks worse than 53.21% on this metric.

Koninklijke Philips NV's average Accounts Receivable for the three months ended in Mar. 2026 was $3,840 Mil. Koninklijke Philips NV's Revenue for the three months ended in Mar. 2026 was $4,514 Mil. Hence, Koninklijke Philips NV's Days Sales Outstanding for the three months ended in Mar. 2026 was 77.63.

The historical rank and industry rank for Koninklijke Philips NV's Days Sales Outstanding or its related term are showing as below:

RYLPF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 68.32   Med: 77.65   Max: 105.32
Current: 68.32

During the past 13 years, Koninklijke Philips NV's highest Days Sales Outstanding was 105.32. The lowest was 68.32. And the median was 77.65.

RYLPF's Days Sales Outstanding is ranked worse than
53.21% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 66.255 vs RYLPF: 68.32

Koninklijke Philips NV's Days Sales Outstanding increased from Mar. 2025 (75.61) to Mar. 2026 (77.63).


Koninklijke Philips NV  (OTCPK:RYLPF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Koninklijke Philips NV Days Sales Outstanding Related Terms


Koninklijke Philips NV Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Koninklijke Philips NV's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koninklijke Philips NV Days Sales Outstanding Chart

Koninklijke Philips NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 82.85 78.09 73.01 72.98 66.32

Koninklijke Philips NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.61 67.61 68.60 59.23 77.63

RYLPF vs ABT, SYK, MDT: Days Sales Outstanding Comparison

For the Medical Devices subindustry, Koninklijke Philips NV's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Koninklijke Philips NV Days Sales Outstanding vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Koninklijke Philips NV's Days Sales Outstanding falls into.


RYLPF
69GF Score
Koninklijke Philips NV RYLPF
Days Sales Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Koninklijke Philips NV Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Koninklijke Philips NV's Days Sales Outstanding for the fiscal year that ended in Dec. 2025 is calculated as

Days Sales Outstanding (A: Dec. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )*Days in Period
=( (3678.534 + 3909.836) / 2 ) / 20882.904*365
=3794.185 / 20882.904*365
=66.32

Koninklijke Philips NV's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding (Q: Mar. 2026 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2025 ) + Accounts Receivable (A: Mar. 2026 )) / count ) / Revenue (A: Mar. 2026 )*Days in Period
=( (3909.836 + 3771.098) / 2 ) / 4514.451*365 / 4
=3840.467 / 4514.451*365 / 4
=77.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 77.63 mean?
Koninklijke Philips NV (RYLPF) has a Days Sales Outstanding of 77.63 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Koninklijke Philips NV and its competitors. This is near median its historical median of 77.65. Over the past decade, Koninklijke Philips NV's Days Sales Outstanding has ranged from 68.32 to 105.32. According to the industry distribution chart, Koninklijke Philips NV ranks #431 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 53.2%.
Is Koninklijke Philips NV's Days Sales Outstanding too high?
Koninklijke Philips NV's current Days Sales Outstanding of 77.63 is near median its 10-year median of 77.65. Over the past 10 years, this metric has ranged from a low of 68.32 to a high of 105.32. The Medical Devices & Instruments industry median Days Sales Outstanding is 66.26. Koninklijke Philips NV's value of 77.63 is 17.2% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #431 out of 810 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #431 out of 810 companies for Days Sales Outstanding. This places Koninklijke Philips NV in the lower half of its industry. The industry median Days Sales Outstanding is 66.26. Koninklijke Philips NV's value of 77.63 is 17.2% above this benchmark. Historically, Koninklijke Philips NV's own Days Sales Outstanding has ranged from 68.32 to 105.32 over the past decade. While the company's 10-year median is 77.65 vs. the industry median of 66.26, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 66.26, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Days Sales Outstanding of 77.63 is 17.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 66.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Days Sales Outstanding is 77.63, which is near median its own 10-year median of 77.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.41, compared to a current price of $26.77 — trading 5.4% above its estimated fair value. The current Days Sales Outstanding is 77.63, which is near median its 10-year median of 77.65 and 17.2% above the Medical Devices & Instruments industry median of 66.26. Koninklijke Philips NV's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Days Sales Outstanding is 77.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of $26.77 is trading 5.4% above its estimated GF Value™ of $25.41. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for RYLPF:

  • Days Sales Outstanding: 77.63 (near median its 10-year median of 77.65)
  • GF Value™: $25.41 vs. price of $26.77 (5.4% above fair value)
  • GF Score™: 69/100 with 2 warning signs
  • Industry Position: 17.2% above the Medical Devices & Instruments median (#431 of 810)

No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
69GF Score

Get the complete analysis for RYLPF

Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.77
Price
$25.41
GF Value